EUROFINS SCIENT (ERFSF) Stock Chart & Stock Price History $80.98 +0.83 (+1.03%) As of 08/15/2025 03:52 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock EUROFINS SCIENT Stock Price Performance The EUROFINS SCIENT (ERFSF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 48.09%, with a year-to-date return of 54.37%. In the past month, the stock has increased 11.69%, reflecting recent market activity. As of the latest close, EUROFINS SCIENT traded at $80.98 with a market cap of $15.63 billion and volume of 565 shares. Five years ago, the stock traded at $809.85, representing a 90.00% decrease over that period. At the time, it had a market cap of $14.03 billion and a volume of 514 shares. Receive ERFSF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for EUROFINS SCIENT and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.18%1 Month Performance+11.69%3 Month Performance+23.99%Year-To-Date Performance+54.37%1 Year Performance+48.09%5 Year Performance-90.00% ERFSF Stock Chart for Monday, August, 18, 2025 ERFSF Chart by TradingView EUROFINS SCIENT Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$80.15$80.98+1.03%$81.36$77.97565 shs$15.63 billion08/14/2025$76.99$80.15+4.11%$80.60$77.39382 shs$15.47 billion08/13/2025$79.13$76.99-2.71%$79.50$76.15417 shs$14.86 billion08/12/2025$75.83$79.13+4.35%$79.13$76.47710 shs$15.27 billion08/11/2025$77.00$75.83-1.51%$78.50$75.83525 shs$14.63 billion08/08/2025$75.00$77.00+2.67%$78.80$75.80446 shs$14.86 billion08/07/2025$76.70$75.00-2.21%$77.45$75.007,028 shs$14.47 billion08/06/2025$78.27$76.70-2.01%$78.32$73.50165 shs$14.80 billion08/05/2025$78.11$78.27+0.21%$78.85$76.54896 shs$15.10 billion08/04/2025$78.10$78.11+0.01%$78.72$74.53928 shs$15.07 billion Get the Latest News and Ratings for ERFSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for EUROFINS SCIENT and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$75.46$78.10+3.50%$78.62$74.87311 shs$15.07 billion07/31/2025$77.19$75.46-2.25%$78.09$75.08555 shs$14.56 billion07/30/2025$78.54$77.19-1.71%$78.11$75.314,838 shs$14.90 billion07/29/2025$77.36$78.54+1.52%$78.67$76.631,093 shs$15.16 billion07/28/2025$82.14$77.36-5.81%$79.81$75.462,079 shs$14.93 billion07/25/2025$76.88$82.14+6.84%$83.02$78.501,165 shs$15.85 billion07/24/2025$76.32$76.88+0.73%$78.23$76.50698 shs$14.84 billion07/23/2025$74.47$76.32+2.48%$76.65$73.73854 shs$14.73 billion07/22/2025$72.00$74.47+3.43%$74.47$72.45794 shs$14.37 billion07/21/2025$72.50$72.00-0.69%$72.13$70.011,553 shs$13.89 billion07/18/2025$72.00$72.50+0.69%$72.50$70.51463 shs$13.99 billion07/17/2025$72.00$72.00+0.00%$72.49$70.231,326 shs$13.89 billion Related Companies COR Stock Price Chart LH Stock Price Chart NTRA Stock Price Chart BMXMF Stock Price Chart CHEOY Stock Price Chart SOLV Stock Price Chart ICLR Stock Price Chart MEDP Stock Price Chart VTRS Stock Price Chart RVTY Stock Price Chart Receive ERFSF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for EUROFINS SCIENT and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ERFSF) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EUROFINS SCIENT Please log in to your account or sign up in order to add this asset to your watchlist. Share EUROFINS SCIENT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access